Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-06-08FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for INTUNIV (guanfacine) by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders [Phase 3]
Phase 3 study evaluating the efficacy and safety of risperidone for preventing relapse in children and adolescents with conduct and other di…
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: Home Based Treatment for Drug Use in Early Adolescents [Phase 2]
Phase 2 clinical trial update on a home-based treatment for drug use in early adolescents, investigating conditions including Attention-Defi…
-
CLINICAL_TRIALS trial_result · 2011-05-25Clinical Trial Update: NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD [Phase 2]
Phase 2 trial comparing NRP104, Adderall XR, and placebo in children aged 6-12 with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity Disorder [Phase 3]
A Phase 3 safety and effectiveness study of methylphenidate HCl extended-release tablets in adults with attention-deficit/hyperactivity diso…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder [Phase 4]
A Phase 4 community-based trial comparing extended-release methylphenidate and atomoxetine in children with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder [Phase 3]
This document reports the completion of a Phase 3 long-term safety study of methylphenidate HCl tablets in adults with Attention Deficit Hyp…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder. [Phase 3]
Phase 3 study evaluating the effectiveness and safety of prolonged-release methylphenidate hydrochloride in adults with Attention-Deficit/Hy…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 2]
Phase 2 clinical trial evaluating methylphenidate's effects on cellular abnormalities in children with ADHD; results posted.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children [Phase 3]
A Phase 3 effectiveness and safety trial comparing CONCERTA with immediate-release methylphenidate in children with ADHD has completed.
-
CLINICAL_TRIALS research · 2011-05-10Clinical Trial Update: Guided Self-Help for Parents of Children With Externalizing Problem Behavior [NA]
This clinical trial update concerns guided self-help for parents of children with externalizing problem behaviors, including Oppositional De…
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD) [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of methylphenidate in children with Attention Deficit Hyperactivity Disorder has c…
-
CLINICAL_TRIALS trial_result · 2011-05-05Clinical Trial Update: Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate [Phase 4]
Phase 4 study update examining brain chemistry via Proton Magnetic Spectroscopy in children and adolescents with attention-deficit/hyperacti…
-
FDA approval · 2011-04-21FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for FOCALIN XR filed by Sandoz Inc. The product contains dexmethylphenidate hydrochloride for th…
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD) [Phase 4]
Phase 4 clinical trial update examining genetic factors that influence atomoxetine response in Attention Deficit Hyperactivity Disorder.
-
CLINICAL_TRIALS research · 2011-04-07Clinical Trial Update: Toolkit for School Behavior Modification in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) [NA]
This clinical trial update describes a toolkit designed to modify school-based behavior in children with ADHD.
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: Sleep and Nocturnal Melatonin in Adults With Attention Deficit Hyperactivity Disorder (ADHD) [NA]
A completed clinical trial evaluating sleep and nocturnal melatonin in adults with attention deficit hyperactivity disorder.
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study [Phase 3]
An open-label extension study for Vyvanse in adolescents evaluated safety and efficacy in a Phase 3 trial.
-
FDA approval · 2011-03-16FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2011-03-16Clinical Trial Update: Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting. [Phase 4]
A Phase 4 trial comparing 30 mg vs 20 mg of dexmethylphenidate extended-release in children aged 6-12 with ADHD, evaluating efficacy and saf…
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Attention-Deficit/Hyperactivity Disorder (ADHD) Brain Activity Changes to Psychostimulants
A completed ADHD clinical trial reports brain activity changes associated with psychostimulant treatment.
-
FDA approval · 2011-03-07FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Strattera (atomoxetine hydrochloride) from Eli Lilly to update the labeling.
-
FDA approval · 2011-02-25FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for INTUNIV (guanfacine) from Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults [NA]
Completed clinical trial evaluating the efficacy of bupropion for attention-deficit/hyperactivity disorder in adults, with participants who …
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) [Phase 1]
Phase 1 pilot cognition study assessing a standardized test battery for adults with ADHD using lisdexamfetamine dimesylate (LDX).